Tetraphase Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
Nov 07, 2016 13:00 pm UTC| Business
WATERTOWN, Mass., Nov. 07, 2016 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections,...
Nov 07, 2016 13:00 pm UTC| Business
Molecular Health GuideTM Workbench Manager for comprehensive, end-to-end clinical decision support Molecular Health GuideTM Clinical Annotation Service for variant analysis and interpretation BOSTON and HEIDELBERG,...
Nov 07, 2016 13:00 pm UTC| Business
Cellvation to Advance Three Programs Licensed from UTHealth Two Phase 2 Studies Supported by Approximately $10M in Secured Grant Funding Frank Taffy to Serve as Interim Chief Executive Officer NEW YORK, Nov. 07, 2016 ...
フォートレス・バイオテック、外傷性脳損傷の新たな治療法を開発するため、子会社セルヴェーション・インクを新設
Nov 07, 2016 13:00 pm UTC| Business
セルヴェーションはUTヘルスからライセンスを取得、3つのプログラムを前進させる 確保済みの助成金約1,000万ドル (約10億円) で2件の第2相試験をサポート フランク・タッフィーが暫定最高経営責任者を務める ニューヨーク発, Nov. ...
Nov 07, 2016 13:00 pm UTC| Business
NEW YORK, Nov. 07, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Twitter, Inc. (“Twitter” or the “Company”) (NYSE:TWTR) and certain of its officers. The class action, filed in United...
Nov 07, 2016 13:00 pm UTC| Business
NEW YORK, Nov. 07, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against MGT Capital Investments, Inc. (“MGT” or the “Company”) (NYSE:MGT) and certain of its officers. The class action,...
Ambarella Announces Q3 FY 2017 Earnings Conference Call to be Held Dec. 1, 2016
Nov 07, 2016 13:00 pm UTC| Business
SANTA CLARA, Calif., Nov. 07, 2016 -- Ambarella, Inc., (NASDAQ:AMBA), a leading developer of low-power, HD and Ultra HD video compression and image processing semiconductors, today announced that it will hold its Q3 FY...